Finance

Beta
Lists
GRCE:NASDAQ
Grace Therapeutics, Inc
$2.30
-3.36%
(-0.080) 1D
$2.24
-2.61% (-0.060)
After hours
Closed: Jun 29, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GRCE...
Open
$2.35
High
$2.44
Low
$2.08
Mkt. cap
37.43M
Avg. vol.
280.44K
Volume
994.74K
52-wk high
$5.18
52-wk low
$1.79
EPS
-$0.47
Beta
1.13
Shares outstanding
16.27M
No. of employees
5
Open
$2.35
High
$2.44
Low
$2.08
Mkt. cap
37.43M
Avg. vol.
280.44K
Volume
994.74K
52-wk high
$5.18
52-wk low
$1.79
EPS
-$0.47
Beta
1.13
Shares outstanding
16.27M
No. of employees
5
News stories
From sources across the web
About Grace Therapeutics, Inc
CEO-
Employees5
Founded2002
Headquarters-
SectorPharmaceutical industry
Websitegracetx.com
Analyst ratings
Based on 2 analysts giving stock ratings to GRCE in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for GRCE in the last 3 months.
Highest
Current $2.30
$8.00 (+247.83%)
Average
$6.00 (+160.87%)
Lowest
$4.00 (+73.91%)
Analyst
Recommendation
Action
Price target
Projected
Date
Chase Knickerbocker
Craig-Hallum
Buy
Reiterated
$4.00
+73.9%
06/22/2026
Stacy Ku
TD Cowen
Buy
Reiterated
$8.00
+247.8%
04/23/2026
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
955.00K
568.00K
462.00K
420.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.14M
1.96M
1.99M
2.59M
Operating expense
3.09M
2.53M
2.45M
3.01M
Total operating expenses
3.09M
2.53M
2.45M
3.01M
Operating income
-3.09M
-2.53M
-2.45M
-3.01M
Other non operating income
-487.00K
1.43M
-42.00K
-
EBT including unusual items
-3.36M
-938.00K
-2.32M
-2.88M
EBT excluding unusual items
-3.36M
-938.00K
-2.32M
-2.88M
Income tax expense
-
-
-
-1.70M
Effective tax rate
-
-
-
59.07%
Other operating expenses
-
-
-
-
Net income
-3.36M
-938.00K
-2.32M
-1.18M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
205.00K
172.00K
172.00K
138.00K
Interest expense
-
-
-
-
Net interest expenses
205.00K
172.00K
172.00K
138.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.09M
-2.53M
-2.45M
-3.01M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer